Riskpilot← Back to searchSign inGet full accessVERDAL APOTEK AS
ASActiveOrg 919413808Jernbanegata 9L, 7650 VerdalRetail sale of pharmaceutical products · NACE 4773Est. 20176 employees
Revenue 2024
NOK 34,4M
+12% vs 2023
EBITDA margin
7.1%
-10% vs 2023
Equity ratio
11.1%
Financial strength
Net profit 2024
NOK 1,8M
-9% vs 2023
| Revenue | NOK 34,4M | +12% |
| EBITDA | NOK 2,4M | -10% |
| Net profit | NOK 1,8M | -9% |
| Total assets | NOK 7M | -9% |
| Equity | NOK 773K | +7% |
| Employees | 6 | — |
Legal name
VERDAL APOTEK AS
Org number
919413808
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
16. august 2017
Share capital
NOK 700 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Company purpose
Eie og drive apotek og annet som naturlig faller sammen med dette.
Address
Jernbanegata 9L, 7650 Verdal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 19 584 | 26 175 | 27 115 | 30 748 | 34 390 |
| Staff expenses | −2 270 | −2 756 | −2 996 | −3 369 | −3 874 |
| EBITDA | 1 854 | 2 299 | 2 398 | 2 689 | 2 428 |
| Depreciation & amort. | −101 | −114 | −202 | −101 | −100 |
| EBIT | 1 754 | 2 185 | 2 197 | 2 589 | 2 328 |
| Net financials | −39 | −41 | −23 | 7 | 43 |
| Profit before tax | 1 714 | 2 143 | 2 173 | 2 596 | 2 371 |
| Tax | 377 | 472 | 478 | 571 | 522 |
| Net profit | 1 337 | 1 672 | 1 695 | 2 025 | 1 849 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 687 | 7 142 | 7 304 | 7 629 | 6 964 |
| Equity | 2 082 | 704 | 799 | 724 | 773 |
| Long-term debt | 1 336 | 1 046 | 737 | 448 | 156 |
| Short-term debt | 3 270 | 5 392 | 5 768 | 6 457 | 6 036 |
| Total debt | 4 605 | 6 438 | 6 505 | 6 905 | 6 192 |
EBITDA margin
7.1%
This company
15.8%
Market median
-55% vs market
20202024
Equity ratio
11.1%
This company
38.2%
Market median
-71% vs market
20202024
Return on equity
239.3%
This company
18.4%
Market median
+1201% vs market
20202024
Net profit margin
5.4%
This company
8.1%
Market median
-33% vs market
20202024
Asset turnover
4.94×
This company
1.12×
Market median
+341% vs market
20202024
Debt / equity
8.01×
This company
0.62×
Market median
-1192% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JT Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
LK Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Chairman | 2021 | |
| Board of Directors | 2023 | |
| Former (3) | ||
| Board of Directors | 2017 – 2021 | |
| Board of Directors | 2021 – 2023 | |
| Board of Directors | 2017 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 49% | 49% | 2022 | |
| Company | 25.57% | 25.57% | 2022 | |
| Company | 25.43% | 25.43% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Pro5 Holding As
VERDAL APOTEK AS Board members of VERDAL APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Kristian Myhre | Chief Executive Officer | 0 companies |
| Jon Torstein Woll | Chief Executive Officer | 0 companies |
| Petter Moi | Board of Directors | 0 companies |
| Vegar Sellæg | Chairman | 0 companies |
| Vegar Sellæg Brenne | Board of Directors | 0 companies |
| Atle Martin Haug | Board of Directors | 0 companies |
| Hanne Aasberg | Board of Directors | 0 companies |
| Jan Erik Helgemo | Board of Directors | 0 companies |